• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018
  • Share to Weibo added to Biovista Vizit October 25, 2017

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

HUMIRA

TNF inhibitors and the microbiome

August 24, 2018Autoimmune Diseases, Microbiome, Vizit Graphs
TNF inhibitors and the microbiome

Study microbiota of patients treated with TNF inhibitors with Biovista Vizit. Explore the live graph.

Vizit Graphs Tag Cloud

CELL PROLIFERATION ERBB-2 ALZHEIMER'S DISEASE METFORMIN NEURODEGENERATIVE DISORDERS SOD1 DIABETES MELLITUS TH17 CELLS STREPTOCOCCUS PNEUMONIAE CANCER INSULIN TP53 STAPHYLOCOCCUS AUREUS APOPTOTIC PROCESS AUTOPHAGY FOXP3 TNF REMICADE HELICOBACTER PYLORI AGING INFLAMMATION RHEUMATOID ARTHRITIS IFNG CASP3 IL23A CELL DIFFERENTIATION PSEUDOMONAS AERUGINOSA DOXORUBICIN 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE RECEPTOR BREAST CANCER CELL DIVISION LISTERIA MONOCYTOGENES ESCHERICHIA COLI ANGIOGENESIS CANDIDA ALBICANS CLOSTRIDIUM DIFFICILE IL6 IL17A PARKINSON DISEASE CTLA4 PORPHYROMONAS GINGIVALIS CELL DEATH IMMUNE RESPONSE CD4

© 2019 Biovista Vizit All Rights Reserved.